Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the mitral valve disease market right now?

There has been significant growth in the market size for mitral valve disease in the past few years. The estimated value of $3 billion in 2024 is expected to increase to $3.3 billion in 2025, marking a compound annual growth rate (CAGR) of 9.8%. The expansion during the historic period can be credited to initiatives taken for patient education, sufficient reimbursement methods and insurance coverage, a surge in health care spending, enhanced awareness and screening initiatives, and broadening market visibility.

How fast Is the mitral valve disease market expected to grow, and what’s its future value?

The market size of mitral valve disease is set to experience a remarkable growth in the coming years, expected to reach $4.73 billion by 2029, boasting a compound annual growth rate (CAGR) of 9.4%. This growth trajectory in the forecasted period can largely be associated with increasing occurrence of mitral valve disease, the growing adoption of minimally invasive procedures, skyrocketing innovation in heart valve surgeries, an increase in venture capital investments, and heightened interest from manufacturers. The forecast period is set to witness critical trends such as technological progress in the field, developments in transcatheter technologies, and further advancements in surgical techniques.

Get your mitral valve disease market report here!

https://www.thebusinessresearchcompany.com/report/mitral-valve-disease-global-market-report

What are the leading drivers of growth in the mitral valve disease market?

The mitral valve disease market is anticipated to expand due to the escalating occurrence of vascular heart diseases. These diseases, which include conditions impacting the blood vessels that serve the heart or are located within the heart itself, result from a combination of lifestyle decisions, demographic shifts, medical conditions, environmental influences, and genetic variations. Vascular heart diseases like ischemic heart disease and hypertension may indirectly lead to mitral valve disease by impacting the heart’s health and functioning, thereby leading to conditions that involve the mitral valve. For example, data from the 2020-21 National Health Survey by the Australian Institute of Health and Welfare revealed that the death rate from cardiovascular disease per 100,000 population in Australia rose from 143.7 in 2021 to 148.2 in 2022 for males. Thus, the rise in vascular heart diseases is propelling the growth of the mitral valve disease market.

What are the key segments defining the mitral valve disease market?

The mitral valve disease market covered in this report is segmented –

1) By Treatment Type: Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy, Mitral Valve Therapeutics

2) By Indication: Mitral Valve Stenosis, Mitral Valve Prolapse, Mitral Valve Regurgitation

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Mitral Valve Repair: Surgical Repair, Minimally Invasive Repair, Percutaneous Mitral Valve Repair

2) By Mitral Valve Replacement: Mechanical Valve Replacement, Biological Valve Replacement, Transcatheter Mitral Valve Replacement (TMVR)

3) By Cardiac Resynchronization Therapy: Pacemaker Therapy, Implantable Cardioverter-Defibrillators (ICD), Biventricular Pacing

4) By Mitral Valve Therapeutics: Pharmacological Treatments, Anticoagulation Therapy, Mitral Valve Repair Devices

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16480&type=smp

Who are the key players steering the development of the mitral valve disease market?

Major companies operating in the mitral valve disease market are Pfizer Inc., Bayer AG, Abbott Laboratories, Novartis AG, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences, ShockWave Medical Inc., Artivion Inc., TTK Health Care Limited, Braile Biomedica, JenaValve Technology Inc., 4C Medical technologies, Labcor Laboratorios Ltda, CryoLife Inc., Valcare Medical, Affluent Medical, Colibri Heart Valve LLC, Coramaze Technologies, Corcym UK Limited, HighLife Medical, Micro International Devices Inc., Neovasc Inc., Mitralign Inc., Transcatheter Technologies GmbH

What are the key trends shaping the future of the mitral valve disease market?

In the mitral valve disease market, principal corporations are innovating stented tissue valves to fulfill the rising interest for less invasive treatment alternatives. These valves are engineered to ensure longevity and credibility, offering patients a secondary option to conventional surgery. For example, in April 2024, the health care firm based in Ireland, Medtronic, unveiled the Avalus Ultra valve, a high-tech surgical aortic tissue valve specially designed for improved user-friendliness during the implant procedure and long-standing patient care. Drawing from ten years of clinical practice with the original Avalus valve, the Avalus Ultra boasts a low valve profile for smoother implantation, a PEEK base frame for uniform circularity, and a top-of-the-industry Effective Orifice Area (EOA) that may help in increasing blood flow. Additionally, it comes with a radiopaque coil that enhances visibility during subsequent valve-in-valve operations.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16480

Which regions are most influential in expanding the mitral valve disease market?

Europe was the largest region in the mitral valve disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mitral valve disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Pigging Valves Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pigging-valves-global-market-report

Aerospace Valves Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/aerospace-valves-global-market-report

Hygienic Pumps And Valves Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hygienic-pumps-and-valves-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: